Results 131 to 140 of about 9,013 (178)
Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry Perspective. [PDF]
Rockman S, Laurie K.
europepmc +1 more source
Human Infection with Avian Influenza A(H10N3) Virus, China, 2024. [PDF]
Wang J +10 more
europepmc +1 more source
Molecular Epidemiology and Genetic Diversity of Influenza B Viruses Based on Whole-Genome Analysis in Japan and Myanmar, 2016-2020. [PDF]
Ichikawa Y +16 more
europepmc +1 more source
Emergence of a novel reassorted high pathogenicity avian influenza A(H5N2) virus associated with severe pneumonia in a young adult. [PDF]
Vázquez-Pérez JA +31 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
UBIQUITOUS REASSORTMENTS IN INFLUENZA A VIRUSES
Journal of Bioinformatics and Computational Biology, 2008The influenza A virus is a negative-stranded RNA virus composed of eight segmented RNA molecules, including polymerases (PB2, PB1, PA), hemagglutinin (HA), nucleoprotein (NP), neuraminidase (NA), matrix protein (MP), and nonstructure gene (NS).
Xiu-Feng Wan, Mufit Ozden, Guohui Lin
openaire +2 more sources
Influenza A Virus Reassortment
2014Reassortment is the process by which influenza viruses swap gene segments. This genetic exchange is possible due to the segmented nature of the viral genome and occurs when two differing influenza viruses co-infect a cell. The viral diversity generated through reassortment is vast and plays an important role in the evolution of influenza viruses ...
John, Steel, Anice C, Lowen
openaire +2 more sources
Is rotavirus a population of reassortants?
Trends in Microbiology, 1995Rotaviruses appear to exist as heterogeneous populations of reassortants and related variants. This phenomenon is consistent with the quasispecies concept of RNA viruses, and suggests that gene reassortment is a crucial evolutionary mechanism for this segmented virus.
V, Gouvea, M, Brantly
openaire +2 more sources
WC3 reassortant vaccines in children
1996Bovine rotavirus strain WC3 (P7[5], G6) administered at the 12th passage level was well tolerated clinically in infants and efficiently induced serum virus neutralizing antibody (VNA) with bovine rotavirus G6 specificity. The protective efficacy of WC3 vaccine against all rotavirus disease was inconsistent, varying in four separate trials from 76% to 0%
H F, Clark +7 more
openaire +2 more sources

